Histamine Determination
The Histamine Determination measures whole-blood histamine to assess mast-cell degranulation in suspected mast-cell activation syndrome, systemic mastocytosis, and acute allergic reactions. Because histamine is rapidly metabolised and highly labile, strict cold-chain handling and timing relative to symptoms are critical; urinary metabolites and serum tryptase are often more practical markers.
1
Biomarkers
Blood (whole blood)
Sample
3–5 business days
Turnaround
Yes
Fasting
What is the Histamine test?
The Histamine Determination measures whole-blood histamine concentration to evaluate mast-cell degranulation and histamine-mediated symptoms. It is part of the work-up for suspected systemic mastocytosis, mast-cell activation syndrome, and certain allergic or anaphylactoid reactions, though its short half-life and strict collection requirements mean that urinary histamine metabolites and serum tryptase are often more practical markers. Practitioners order whole-blood histamine when symptoms are episodic and can be captured during or immediately after an episode, or as part of a panel investigating flushing, urticaria, angioedema, unexplained hypotension, or gastrointestinal symptoms thought to arise from mast-cell mediator release. Interpretation demands knowledge of the timing of collection relative to symptoms, adherence to handling protocols, and integration with tryptase, urinary methylhistamine, and clinical context.
What does the Histamine test measure?
Histamine is a biogenic amine synthesised from L-histidine by histidine decarboxylase and stored in mast-cell and basophil granules. Upon degranulation it is released into plasma, where it acts through H1–H4 receptors to mediate allergic and inflammatory responses, regulate gastric acid secretion, and modulate neurotransmission. Circulating histamine is rapidly metabolised by diamine oxidase and histamine N-methyltransferase, yielding a plasma half-life measured in minutes; steady-state concentration reflects the balance between ongoing release and clearance.
Whole-blood histamine captures both intra- and extracellular pools and is used to assess mast-cell activation and degranulation. Markedly elevated concentrations suggest systemic mastocytosis or mast-cell activation syndrome when other causes of histamine release are excluded. Because of rapid metabolism and collection sensitivity, urinary metabolites (N-methylhistamine, histamine itself) are often preferred for diagnosing these disorders; plasma histamine is most useful when drawn during symptomatic episodes or in acute settings.
Why is the Histamine test ordered?
- Investigation of suspected mast-cell activation syndrome in patients with recurrent flushing, urticaria, gastrointestinal disturbance, or anaphylactoid episodes
- Work-up of systemic mastocytosis when bone-marrow and tryptase findings suggest mast-cell burden, and mediator release is being quantified
- Assessment of histamine-mediated reactions during or immediately after acute allergic or anaphylactoid events, where collection can be timed to symptom onset
- Evaluation of unexplained episodic hypotension, tachycardia, or syncope when a mediator-release disorder is in the differential
- Monitoring response to mast-cell stabiliser or antihistamine therapy in diagnosed mediator-release syndromes, though urinary markers are usually preferred
- Differential diagnosis of carcinoid syndrome and other neuroendocrine tumours that may also produce vasoactive amines, interpreted alongside serotonin and 5-HIAA
Sample collection and turnaround
Sample type
Blood (whole blood)
Fasting required
Yes
Collection method
Venipuncture at patient service centre
Turnaround
3–5 business days
Collection notes
Phlebotomy via LabCorp draw site. Whole blood collected into pre-chilled tubes (EDTA or heparin as specified by the laboratory), placed immediately on wet ice, and centrifuged refrigerated within 30 minutes. Patient should fast for at least eight hours and avoid histamine-rich foods (fermented, aged, or processed items) for 24 hours before the draw. Ideally collect during or within 30–60 minutes of a symptomatic episode; samples drawn when asymptomatic may be uninformative.
Specimen requirements
Minimum 2 mL whole blood in pre-chilled anticoagulant tube. Immediate icing and cold centrifugation mandatory; plasma separated and frozen within one hour of collection. Specimens not handled cold should be rejected.
What can affect Histamine results?
Whole blood must be collected into pre-chilled tubes, placed immediately on ice, and centrifuged cold; delay or warm handling triggers spontaneous degranulation, spuriously raising histamine and rendering the result uninterpretable.
Plasma histamine peaks within minutes of mast-cell degranulation and falls rapidly; samples drawn outside symptomatic episodes or more than an hour after an event are often normal despite true mediator release.
Fermented foods, aged cheese, processed meats, and some fish can transiently raise blood histamine; fasting and avoidance of these for 24 hours before the test reduce dietary interference.
Reduced DAO activity (genetic, drug-induced, or secondary to gastrointestinal disease) impairs histamine catabolism, raising circulating levels independent of increased release.
Opiates, radiocontrast media, and some neuromuscular blockers can provoke mast-cell release; monoamine oxidase inhibitors and alcohol can impair histamine breakdown. A full medication history is essential.
Acute stress can provoke mast-cell activation; collection under calm, standardised conditions improves interpretability.
What do Histamine results mean?
Elevated
Mast-cell activation syndrome, systemic mastocytosis, anaphylaxis or anaphylactoid reaction (if drawn during the event), carcinoid syndrome (interpreted with serotonin and 5-HIAA), and diamine oxidase deficiency. Spurious elevation from poor handling or histamine-rich food ingestion must be excluded before attributing the result to disease.
Normal
A normal histamine concentration between symptomatic episodes is expected and does not rule out mast-cell activation syndrome or mastocytosis. If the clinical suspicion is high, repeat sampling during symptoms or measure urinary methylhistamine and serum tryptase.
Reduced
Low or undetectable histamine is normal in the fasting, asymptomatic state and does not exclude a mast-cell disorder; the test is informative only when drawn during or shortly after symptoms.
Note: Whole-blood histamine is highly labile and pre-analytically sensitive; strict cold-chain handling is mandatory. Urinary histamine metabolites (N-methylhistamine) and serum tryptase are often more robust markers. Interpretation requires correlation with the timing of collection, dietary and medication history, and the broader mast-cell work-up.
Frequently asked questions
Whole-blood histamine captures a snapshot of circulating histamine at the moment of collection and falls rapidly after release, so it must be drawn during symptoms. Urinary N-methylhistamine integrates release over hours and is less pre-analytically fragile, making it the preferred marker for episodic mast-cell activation.
How to access the Histamine test
The Histamine reference page is free and open to all practitioners. Create a free practitioner account to see pricing, save tests to your list, and generate requisition forms. Verification takes 1–2 business days.
Create Free AccountAbout this page
Published: October 7, 2026
Last reviewed: October 7, 2026
- Valent P, et al. Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal. Int Arch Allergy Immunol. (2012)
- Akin C, et al. Mast cell activation syndrome: proposed diagnostic criteria. J Allergy Clin Immunol. (2010)
- Schwelberger HG. Histamine N-methyltransferase (HNMT) enzyme and gene. In: Falus A, ed. Histamine: Biology and Medical Aspects. SpringMed Publishing. (2004)
- Maintz L, Novak N. Histamine and histamine intolerance. Am J Clin Nutr. (2007)
This content is for licensed healthcare practitioners only and does not constitute medical advice. Clinical decisions should be based on the full clinical picture and not on any single test result.